LLY
NYSE
$1,146.37
Lilly(Eli) & Company (LLY)
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Buy
Target: $1,270.37 (+10.82%)
Market Cap
$1.03T
PEG Ratio
0.19
EPS 5Y CAGR
+29.14%
Revenue 5Y CAGR
+23.17%
Price Chart
Valuation
Market Cap$1.03T
P/E48.44
Forward P/E33.67
PEG0.19
P/S14.28
P/B32.94
Profitability
Total Revenue (TTM)$72B
Gross Profit (TTM)$60B
EBITDA$34B
Profit Margin37.4%
EPS$23.87
Financial Health
Debt-to-Equity139%
Free Cash Flow Yield1.98%
Dividend Yield0.53%
Growth & Risk
EPS 5Y CAGR+29.14%
Revenue 5Y CAGR+23.17%
FCF 5Y CAGR+21.25%
Dividends 5Y CAGR+20.14%
Beta (5Y)0.65
Sharpe Ratio1.18